{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:12:38Z","timestamp":1793103158834,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ticks and Tick-borne Diseases"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ttbdis.2025.102454","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T20:14:38Z","timestamp":1739477678000},"page":"102454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Estimation of medically-attended LB incidence in Norway, Finland and Poland using data from national surveillance and published literature"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1306-5474","authenticated-orcid":false,"given":"Gordon","family":"Brestrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0083-9379","authenticated-orcid":false,"given":"Madiha","family":"Shafquat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3120-7704","authenticated-orcid":false,"given":"Frederick J.","family":"Angulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2477-7794","authenticated-orcid":false,"given":"Alexander","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6666-5644","authenticated-orcid":false,"given":"Kristian","family":"Lie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Halsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1327-484X","authenticated-orcid":false,"given":"Julie","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Mo\u00efsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0728-876X","authenticated-orcid":false,"given":"James H.","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ttbdis.2025.102454_bib0001","series-title":"Zentralinstitut f\u00fcr die kassen\u00e4rztliche Versorgung in Deutschland","article-title":"Bundesweite und kleinr\u00e4umige Kennzahlen zur morbidit\u00e4t von Lyme\u2011Borreliose in Deutschland anhand vertrags\u00e4rztlicher abrechnungdaten, 2010 bis 2019","author":"Akmatov","year":"2021"},{"key":"10.1016\/j.ttbdis.2025.102454_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107242","article-title":"Incidence of symptomatic Lyme borreliosis in nine European countries","volume":"149","author":"Angulo","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0003","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJM199511163332004","article-title":"An epidemiologic study of Lyme disease in southern Sweden","volume":"333","author":"Berglund","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0004","article-title":"Excess healthcare costs and resource utilisation of Lyme borreliosis in Germany: a propensity score\u2013matched cohort study","author":"Brestrich","year":"2024","journal-title":"Zoonoses. Public Health"},{"key":"10.1016\/j.ttbdis.2025.102454_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ttbdis.2024.102326","article-title":"Incidence of Lyme borreliosis in Germany: a retrospective observational healthcare claims study","volume":"15","author":"Brestrich","year":"2024","journal-title":"Ticks. Tick. Borne Dis."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0006","doi-asserted-by":"crossref","first-page":"277","DOI":"10.26444\/aaem\/121056","article-title":"The problem of Lyme borreliosis infections in urban and rural residents in Poland, based on National Health Fund data","volume":"28","author":"Brzozowska","year":"2021","journal-title":"Ann. Agric. Environ. Med."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0007","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/vbz.2022.0071","article-title":"Incidence of Lyme borreliosis in Europe from national surveillance systems (2005\u20132020)","volume":"23","author":"Burn","year":"2023","journal-title":"Vector. Borne Zoonotic. Dis."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025916","article-title":"Incidence of Lyme disease in the UK: a population-based cohort study","volume":"9","author":"Cairns","year":"2019","journal-title":"BMJ Open."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0009","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3201\/eid2909.221931","article-title":"Validation of claims-based algorithm for Lyme disease, Massachusetts, USA","volume":"29","author":"Cocoros","year":"2023","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ttbdis.2025.102454_bib43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.advms.2015.10.007","article-title":"Lyme disease in Poland - A serious problem?","volume":"61","author":"Czupryna","year":"2016","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0011","unstructured":"Department of Epidemiology and Surveillance of Infectious Diseases, 2022. Infectious diseases and poisonings in Poland. https:\/\/wwwold.pzh.gov.pl\/oldpage\/epimeld\/index_a.html#Page%20top."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ttbdis.2016.06.006","article-title":"Incidence and antibiotic treatment of erythema migrans in Norway 2005-2009","volume":"8","author":"Eliassen","year":"2017","journal-title":"Ticks. Tick. Borne Dis."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0013","doi-asserted-by":"crossref","first-page":"14976","DOI":"10.1038\/s41598-018-33136-0","article-title":"Incidence of notified Lyme borreliosis in Germany, 2013-2017","volume":"8","author":"Enkelmann","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0014","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10096-012-1768-6","article-title":"Management of paediatric Lyme disease in non-endemic and endemic areas: data from the Registry of the Italian Society for Pediatric Infectious Diseases","volume":"32","author":"Esposito","year":"2013","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1186\/s12879-020-05555-w","article-title":"Lyme borreliosis in Finland: a register-based linkage study","volume":"20","author":"Feuth","year":"2020","journal-title":"BMC. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0016","unstructured":"Folkehelseinstituttet, 2024. Meldingssystem for smittsomme sykdommer (MSIS). https:\/\/msis.no."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0017","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1186\/s12889-022-14380-6","article-title":"Lyme borreliosis in Belgium: a cost-of-illness analysis","volume":"22","author":"Geebelen","year":"2022","journal-title":"BMC. Public Health"},{"key":"10.1016\/j.ttbdis.2025.102454_bib0018","series-title":"Finland: Health System review, Health Systems in Transition","first-page":"166","author":"Keskim\u00e4ki","year":"2019"},{"key":"10.1016\/j.ttbdis.2025.102454_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.healthpol.2023.104820","article-title":"Private health insurance in the universal public healthcare system: the role of healthcare provision in Finland","volume":"132","author":"Lavaste","year":"2023","journal-title":"Health Policy. (New. York)"},{"key":"10.1016\/j.ttbdis.2025.102454_bib0021","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/595427","article-title":"Evaluating frequency, diagnostic quality, and cost of lyme borreliosis testing in Germany: a retrospective model analysis","volume":"2012","author":"M\u00fcller","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0020","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1186\/s12889-016-3346-9","article-title":"Are the current notification criteria for Lyme borreliosis in Norway suitable? Results of an evaluation of lyme borreliosis surveillance in Norway, 1995-2013","volume":"16","author":"MacDonald","year":"2016","journal-title":"BMC. Public Health"},{"key":"10.1016\/j.ttbdis.2025.102454_bib0022","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3201\/eid3007.230942","article-title":"Electronic health record data for Lyme disease surveillance, Massachusetts, USA, 2017-2018","volume":"30","author":"Nagavedu","year":"2024","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276299","article-title":"Healthcare claims-based Lyme disease case-finding algorithms in the United States: a systematic literature review","volume":"17","author":"Nam","year":"2022","journal-title":"PLoS. One"},{"key":"10.1016\/j.ttbdis.2025.102454_bib0024","unstructured":"Oriola Insights Real-World Evidence and Market Access self-service reporting, 2024. Data from Finnish national healthcare registries. https:\/\/www.oriola.com\/services\/pharmaceutical-companies\/real-world-evidence."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/vbz.2022.0049","article-title":"A retrospective database study of Lyme borreliosis incidence in Poland from 2015 to 2019: a public health concern","volume":"23","author":"Paradowska-Stankiewicz","year":"2023","journal-title":"Vector. Borne Zoonotic. Dis."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0026","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s11686-021-00495-0","article-title":"The impact of a pandemic COVID-19 on the incidence of borreliosis in Poland","volume":"67","author":"Piotrowski","year":"2022","journal-title":"Acta Parasitol."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0027","unstructured":"Polish Chamber of Insurance (PIU), 2023. Over 4 million Poles use private health insurance."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0028","unstructured":"Robert Koch Institute, 2017. Meldepflichtige Krankheiten und krankheitserreger \u00dcbersichtstabelle. https:\/\/www.rki.de\/DE\/Content\/Infekt\/IfSG\/Meldepflichtige_Krankheiten\/Meldepflichtige_Krankheiten_Erreger.pdf?__blob=publicationFile."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0029","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3201\/eid2308.161273","article-title":"Lyme borreliosis in Finland, 1995-2014","volume":"23","author":"Sajanti","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0030","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1089\/vbz.2022.0047","article-title":"Incidence of Lyme borreliosis in Finland: exploring observed trends over time using public surveillance data, 2015-2020","volume":"23","author":"Skufca","year":"2023","journal-title":"Vector. Borne Zoonotic. Dis."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0032","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/femsre\/fux047","article-title":"Lyme borreliosis: from tick bite to diagnosis and treatment","volume":"42","author":"Stanek","year":"2018","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0031","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","article-title":"Lyme borreliosis: clinical case definitions for diagnosis and management in Europe","volume":"17","author":"Stanek","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0033","unstructured":"Statistics Finland, 2024. Key figures on population by area, information and year. https:\/\/pxdata.stat.fi\/PxWeb\/pxweb\/en\/StatFin\/StatFin__vaerak\/statfin_vaerak_pxt_11ra.px\/."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0034","unstructured":"Statistics Norway, 2024. Population. https:\/\/www.ssb.no\/en\/befolkning\/folketall\/statistikk\/befolkning."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0035","unstructured":"Statistics Poland, 2024. Tabl. 7 population and vital statistics. https:\/\/stat.gov.pl\/en\/topics\/other-studies\/informations-on-socio-economic-situation\/statistical-bulletin-no-72024,4,165.html."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0036","first-page":"74","article-title":"An estimate of lyme borreliosis incidence in Western Europe","volume":"39","author":"Sykes","year":"2017","journal-title":"J. Public Health"},{"key":"10.1016\/j.ttbdis.2025.102454_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ttbdis.2020.101549","article-title":"Changes in Lyme neuroborreliosis incidence in Denmark, 1996 to 2015","volume":"11","author":"Tetens","year":"2020","journal-title":"Ticks. Tick. Borne Dis."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0038","unstructured":"The National Institute for Health and Welfare (THL), 2024a. Finnish national infectious diseases register, statistical database - cases. https:\/\/sampo.thl.fi\/pivot\/prod\/en\/ttr\/cases\/fact_ttr_cases?&row=nidrreportgroup-878234&column=yearmonth-878344."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0039","unstructured":"The National Institute for Health and Welfare (THL), 2024b. Lyme borreliosis register surveillance. https:\/\/sampo.thl.fi\/pivot\/prod\/fi\/infestat\/borre\/fact_infestat_borre?column=weeks-546468&row=hcdmunicipality2020-572572&filter=measure-546834."},{"key":"10.1016\/j.ttbdis.2025.102454_bib0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0168-8510(00)00141-X","article-title":"Health care under transformation in Poland","volume":"56","author":"Tymowska","year":"2001","journal-title":"Health Policy. (New. York)"},{"key":"10.1016\/j.ttbdis.2025.102454_bib0041","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/eurpub\/ckw269","article-title":"The cost of lyme borreliosis","volume":"27","author":"van den Wijngaard","year":"2017","journal-title":"Eur. J. Public Health"},{"key":"10.1016\/j.ttbdis.2025.102454_bib0042","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s10096-012-1580-3","article-title":"Incidence and management of presumption of Lyme borreliosis in Belgium: recent data from the sentinel network of general practitioners","volume":"31","author":"Vanthomme","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."}],"container-title":["Ticks and Tick-borne Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877959X25000184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877959X25000184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:06:18Z","timestamp":1762560378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877959X25000184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1877959X25000184"],"URL":"https:\/\/doi.org\/10.1016\/j.ttbdis.2025.102454","relation":{},"ISSN":["1877-959X"],"issn-type":[{"value":"1877-959X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimation of medically-attended LB incidence in Norway, Finland and Poland using data from national surveillance and published literature","name":"articletitle","label":"Article Title"},{"value":"Ticks and Tick-borne Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ttbdis.2025.102454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Pfizer Pharmaceuticals. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"102454"}}